Our partners in Takara offer a broad range of innovative technologies to accelerate your cancer research discovery and therapeutic workflows spanning from tools for cancer biomarker disovery, single cell cancer cell analysis, cancer epigenomic analysis, HLA typing, T-cell therapy and profiling, antibody therapeutics and CRISPR/Cas9 gene editing.
Cancer biomarker discovery has been greatly faciliated by Next-Generation Sequencing (NGS) analysis of circulating nucleic acids within blood, urine, saliva, pleural effusinons, and cerebrospinal fluid which can contain tumour-derived genetic information. NGS a powerful tool in biomarker detection and discovery. NGS is a high-throughput genome sequencing technology that facilitates sequencing of complete genomes or thousands of mutations simultaneously in a cost-effective manner. See our range of NGS Libary Kits here and our SMARTer® ThruPLEX® DNA-seq 48D Kit
To see our full range of Takara products click here
Read Takara’s solution for cancer research where they discuss the following topics
- Cancer Biomarker Discovery
- Single Cancer Cell Analysis
- Cancer Genomics and Epigenomics
- HLA typing for cancer
- Cancer Immunotherapy (T-Cell Therapy, TCR Profiling, Antibody Therapeutics)
- CRISPR/Cas9 Gene Editing for Cancer Therapy & Drug discovery
To download article click here
To get in touch with our Life Science team for further information, please fill in form below.